NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity & Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Obesity Pathogenesis



ENPP1, an insulin receptor inhibitor, is a genetic link between obesity and diabetes



May 15th, 2006

ENPP1, an inhibitor of the insulin receptor, is a genetic link between childhood and adult obesity and type 2 diabetes.

According to recent research from France, "Clinical studies have established the strong link between obesity and type 2 diabetes, especially in children, where the rising prevalence of childhood severe obesity has preceded the recent emergence of early-onset forms of 'diabesity'. These data suggested a common genetic background shared by both conditions, which was also supported by the identification by genome scans of several diabesity chromosomal regions of linkage."

"The genetic investigation of early-onset form of familial...


Source: Obesity & Diabetes Week (2006-05-15)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login